Getinge AB Stock

Equities

GETI B

SE0000202624

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq Stockholm 11:29:37 2024-05-28 EDT 5-day change 1st Jan Change
191.4 SEK -0.36% Intraday chart for Getinge AB +2.57% -14.65%

Financials

Sales 2024 * 33.94B 3.21B 4.38B Sales 2025 * 35.71B 3.37B 4.61B Capitalization 52.15B 4.93B 6.73B
Net income 2024 * 2.79B 264M 360M Net income 2025 * 3.25B 307M 419M EV / Sales 2024 * 1.72 x
Net Debt 2024 * 6.4B 605M 826M Net Debt 2025 * 4.38B 414M 565M EV / Sales 2025 * 1.58 x
P/E ratio 2024 *
19.1 x
P/E ratio 2025 *
16.2 x
Employees 11,862
Yield 2024 *
2.48%
Yield 2025 *
2.77%
Free-Float 79.06%
More Fundamentals * Assessed data
Dynamic Chart
1 day-0.36%
1 week+2.57%
Current month-18.53%
1 month-18.57%
3 months-6.66%
6 months-14.03%
Current year-14.65%
More quotes
1 week
183.10
Extreme 183.1
194.50
1 month
182.40
Extreme 182.4
239.70
Current year
182.40
Extreme 182.4
240.20
1 year
174.20
Extreme 174.2
268.80
3 years
174.20
Extreme 174.2
431.60
5 years
126.70
Extreme 126.7
431.60
10 years
74.74
Extreme 74.74
431.60
More quotes
Managers TitleAgeSince
Chief Executive Officer 52 17-04-30
Director of Finance/CFO - 22-09-14
Chairman 63 96-12-31
Members of the board TitleAgeSince
Director/Board Member 68 06-12-31
Director/Board Member 73 88-12-31
Chairman 63 96-12-31
More insiders
Date Price Change Volume
24-05-28 191.4 -0.36% 887,150
24-05-27 192.2 +0.60% 1,177,678
24-05-24 191 +1.00% 1,624,070
24-05-23 189.1 +1.86% 2,037,816
24-05-22 185.6 -0.54% 1,226,173

Delayed Quote Nasdaq Stockholm, May 28, 2024 at 11:29 am

More quotes
Getinge AB is the world's leader in producing and marketing medical equipment intended to health care facilities (clinics, hospitals, rest homes, etc.). Net sales break down by family of products as follows: - medical systems (57.4%): equipment for operating rooms (primarily tables and lighting systems), ventilators and heart and lung machines, etc.; - hospital sterilization equipment (29.4%); - contamination prevention equipment (13.2%): in the fields of biopharmaceutical production, biomedical research, manufacturing of medical devices and laboratory applications. Net sales break down by source of income into sales of equipment (45.3%), consumables (37.1%), services and spare parts (17.6%). At the end of 2021, the group had 20 production sites worldwide. Net sales are distributed geographically as follows: Sweden (1.8%), Europe/Middle East/Africa (35.8%), Americas (37.9%) and Asia/Pacific (24.5%).
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
10
Last Close Price
191.4 SEK
Average target price
229.2 SEK
Spread / Average Target
+19.73%
Consensus
  1. Stock Market
  2. Equities
  3. GETI B Stock